Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression

Published:2024-03 Issue: Volume:348 Page:143-151
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Parikh Sagar V.,Vande Voort Jennifer L.,Yocum Anastasia K.,Achtyes Eric,Goes Fernando S.,Nykamp Louis,Singh Balwinder,Lopez-Vives Daniela,Sera Cortney E.,Maixner Daniel,Tarnal Vijay,Severe Jennifer,Bartek Steven,Tye Susannah J.,Rico Jose,Stoppel Cynthia J.,Becerra Alexis,Smart LeAnn,Miller Christina R.,Frye Mark A.,Greden John F.,Bobo William V.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference47 articles.

1. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression;Aan Het Rot;Biol. Psychiatry,2010

2. Diagnostic and Statistical Manual of Mental Disorders,2013

3. Assessment of suicidal intention: the Scale for Suicide Ideation;Beck;J. Consult. Clin. Psychol.,1979

4. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy;Caddy;Ther. Adv. Psychopharmacol.,2014

5. Bipolar disorder;Carvalho;N. Engl. J. Med.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP